Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE54.7200
- TODAY'S CHANGE (%)-4.9400 (-8.2803%)
- Bid / Lots51.5900/ 8
- Ask / Lots86.0000/ 1
- Open / Previous Close60.1300 / 59.6600
- Day Range
- 52 Week Range
- Volume908,877
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 22892 | 59.84 |
| 09:33 ET | 844 | 60.1 |
| 09:35 ET | 1300 | 60.12 |
| 09:37 ET | 1000 | 59.51 |
| 09:39 ET | 200 | 59.21 |
| 09:42 ET | 500 | 58.8 |
| 09:44 ET | 3995 | 58.74 |
| 09:46 ET | 3241 | 58.3 |
| 09:48 ET | 1740 | 57.921 |
| 09:50 ET | 2958 | 57.94 |
| 09:51 ET | 2075 | 58 |
| 09:53 ET | 1936 | 58.61 |
| 09:55 ET | 200 | 58.55 |
| 09:57 ET | 300 | 58.395 |
| 10:00 ET | 400 | 58.445 |
| 10:02 ET | 3395 | 58.38 |
| 10:04 ET | 100 | 58.38 |
| 10:06 ET | 300 | 58.06 |
| 10:08 ET | 2104 | 57.74 |
| 10:09 ET | 23612 | 57.04 |
| 10:11 ET | 5694 | 57.54 |
| 10:13 ET | 1509 | 57.31 |
| 10:15 ET | 739 | 57.53 |
| 10:18 ET | 1101 | 57.34 |
| 10:20 ET | 900 | 57.33 |
| 10:22 ET | 1100 | 57.36 |
| 10:24 ET | 1000 | 57.13 |
| 10:26 ET | 3042 | 57.0931 |
| 10:27 ET | 400 | 57.29 |
| 10:29 ET | 1723 | 57.38 |
| 10:31 ET | 7300 | 57.22 |
| 10:33 ET | 1783 | 57.23 |
| 10:36 ET | 100 | 56.96 |
| 10:38 ET | 1200 | 56.71 |
| 10:40 ET | 1912 | 57.055 |
| 10:42 ET | 2049 | 56.83 |
| 10:44 ET | 955 | 56.885 |
| 10:45 ET | 940 | 56.87 |
| 10:47 ET | 640 | 56.785 |
| 10:49 ET | 720 | 56.825 |
| 10:51 ET | 2170 | 56.94 |
| 10:54 ET | 2404 | 56.65 |
| 10:56 ET | 7920 | 56.62 |
| 10:58 ET | 4709 | 56.55 |
| 11:00 ET | 7060 | 56.675 |
| 11:02 ET | 10336 | 56.255 |
| 11:03 ET | 1595 | 56.41 |
| 11:05 ET | 1020 | 56.24 |
| 11:07 ET | 1002 | 56.415 |
| 11:09 ET | 912 | 56.47 |
| 11:12 ET | 500 | 56.38 |
| 11:14 ET | 3600 | 56.21 |
| 11:16 ET | 4257 | 56.26 |
| 11:18 ET | 19957 | 56.385 |
| 11:20 ET | 800 | 56.195 |
| 11:21 ET | 1000 | 56.01 |
| 11:23 ET | 3853 | 56.36 |
| 11:25 ET | 7922 | 56.39 |
| 11:27 ET | 800 | 56.245 |
| 11:30 ET | 700 | 56.06 |
| 11:32 ET | 1150 | 55.86 |
| 11:34 ET | 300 | 55.86 |
| 11:36 ET | 1500 | 55.87 |
| 11:38 ET | 4824 | 55.59 |
| 11:39 ET | 9059 | 55.89 |
| 11:41 ET | 400 | 55.86 |
| 11:43 ET | 3599 | 55.905 |
| 11:45 ET | 100 | 55.99 |
| 11:48 ET | 3800 | 55.77 |
| 11:50 ET | 300 | 55.705 |
| 11:52 ET | 4333 | 56.03 |
| 11:54 ET | 1278 | 55.96 |
| 11:56 ET | 100 | 55.98 |
| 11:57 ET | 100 | 55.91 |
| 11:59 ET | 1000 | 55.89 |
| 12:01 ET | 3340 | 55.89 |
| 12:03 ET | 1600 | 55.79 |
| 12:06 ET | 795 | 55.77 |
| 12:08 ET | 1900 | 55.445 |
| 12:10 ET | 2038 | 55.395 |
| 12:12 ET | 100 | 55.36 |
| 12:14 ET | 738 | 55.31 |
| 12:15 ET | 1300 | 55.375 |
| 12:17 ET | 1040 | 55.335 |
| 12:19 ET | 1977 | 55.58 |
| 12:21 ET | 1096 | 55.635 |
| 12:24 ET | 1617 | 55.76 |
| 12:26 ET | 400 | 55.65 |
| 12:28 ET | 300 | 55.62 |
| 12:30 ET | 200 | 55.63 |
| 12:32 ET | 2401 | 55.675 |
| 12:33 ET | 709 | 55.54 |
| 12:35 ET | 1300 | 55.465 |
| 12:37 ET | 2003 | 55.71 |
| 12:39 ET | 1095 | 55.74 |
| 12:42 ET | 100 | 55.765 |
| 12:44 ET | 600 | 55.65 |
| 12:46 ET | 4651 | 55.6925 |
| 12:48 ET | 3200 | 55.71 |
| 12:50 ET | 570 | 55.695 |
| 12:51 ET | 300 | 55.6 |
| 12:53 ET | 300 | 55.53 |
| 12:55 ET | 1335 | 55.47 |
| 12:57 ET | 100 | 55.43 |
| 01:00 ET | 1248 | 55.37 |
| 01:02 ET | 4134 | 55.48 |
| 01:04 ET | 200 | 55.475 |
| 01:06 ET | 1100 | 55.41 |
| 01:08 ET | 1300 | 55.51 |
| 01:09 ET | 100 | 55.525 |
| 01:11 ET | 1030 | 55.54 |
| 01:13 ET | 1700 | 55.445 |
| 01:15 ET | 700 | 55.47 |
| 01:18 ET | 700 | 55.455 |
| 01:20 ET | 1500 | 55.38 |
| 01:22 ET | 4710 | 55.3 |
| 01:24 ET | 2300 | 55.43 |
| 01:26 ET | 1100 | 55.355 |
| 01:27 ET | 400 | 55.445 |
| 01:29 ET | 601 | 55.44 |
| 01:31 ET | 900 | 55.485 |
| 01:33 ET | 466 | 55.44 |
| 01:36 ET | 764 | 55.435 |
| 01:38 ET | 700 | 55.42 |
| 01:40 ET | 400 | 55.28 |
| 01:42 ET | 600 | 55.27 |
| 01:44 ET | 300 | 55.24 |
| 01:45 ET | 3527 | 55.15 |
| 01:47 ET | 2584 | 55.16 |
| 01:49 ET | 3511 | 54.9 |
| 01:51 ET | 500 | 54.95 |
| 01:54 ET | 500 | 55.01 |
| 01:56 ET | 4994 | 55 |
| 01:58 ET | 100 | 54.96 |
| 02:00 ET | 3992 | 54.96 |
| 02:02 ET | 1308 | 55.045 |
| 02:03 ET | 2224 | 55.06 |
| 02:05 ET | 2500 | 55.08 |
| 02:07 ET | 200 | 55.095 |
| 02:09 ET | 1000 | 55.14 |
| 02:12 ET | 5856 | 55.04 |
| 02:14 ET | 500 | 54.985 |
| 02:16 ET | 200 | 54.87 |
| 02:18 ET | 1876 | 54.79 |
| 02:20 ET | 1135 | 54.79 |
| 02:21 ET | 980 | 54.75 |
| 02:23 ET | 1610 | 54.55 |
| 02:25 ET | 4899 | 54.59 |
| 02:27 ET | 500 | 54.63 |
| 02:30 ET | 800 | 54.59 |
| 02:32 ET | 512 | 54.58 |
| 02:34 ET | 300 | 54.65 |
| 02:36 ET | 1606 | 54.77 |
| 02:38 ET | 200 | 54.69 |
| 02:39 ET | 1300 | 54.73 |
| 02:41 ET | 1256 | 54.9 |
| 02:43 ET | 2109 | 54.93 |
| 02:45 ET | 1047 | 54.85 |
| 03:14 ET | 500 | 54.68 |
| 03:15 ET | 1600 | 54.57 |
| 03:17 ET | 1200 | 54.51 |
| 03:19 ET | 1480 | 54.42 |
| 03:21 ET | 4319 | 54.58 |
| 03:24 ET | 1659 | 54.555 |
| 03:26 ET | 4400 | 54.57 |
| 03:28 ET | 2300 | 54.575 |
| 03:30 ET | 1300 | 54.54 |
| 03:32 ET | 2066 | 54.485 |
| 03:33 ET | 3520 | 54.56 |
| 03:35 ET | 6659 | 54.605 |
| 03:37 ET | 1651 | 54.705 |
| 03:39 ET | 1500 | 54.79 |
| 03:42 ET | 1220 | 54.86 |
| 03:44 ET | 6023 | 54.585 |
| 03:46 ET | 2300 | 54.685 |
| 03:48 ET | 700 | 54.71 |
| 03:50 ET | 2104 | 54.615 |
| 03:51 ET | 1303 | 54.51 |
| 03:53 ET | 1778 | 54.52 |
| 03:55 ET | 5259 | 54.475 |
| 03:57 ET | 11306 | 54.69 |
| 04:00 ET | 173154 | 54.72 |
Nov 15, 2024
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences, from 9:00AM ET on Friday Nov 15, 2024 by Dow Jones
9:00AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 14, 2024
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting, from 4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
4:05PM ET on Thursday Nov 14, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Is Maintained at Buy by Citigroup, from 1:44PM ET on Thursday Nov 14, 2024 by Dow Jones
1:44PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co., from 1:57PM ET on Wednesday Nov 13, 2024 by Dow Jones
1:57PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.9B | -14.7x | --- |
Avidity Biosciences Inc | 5.0B | -14.6x | --- |
Krystal Biotech Inc | 4.9B | 96.6x | --- |
BridgeBio Pharma Inc | 4.5B | -9.8x | --- |
Biohaven Ltd | 4.4B | -4.7x | --- |
Viking Therapeutics Inc | 5.5B | -52.9x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.9B |
|---|---|
Revenue (TTM) | $1.0M |
Shares Outstanding | 89.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.60 |
EPS | $-3.72 |
Book Value | $7.91 |
P/E Ratio | -14.7x |
Price/Sales (TTM) | 4,704.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -29,525.22% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
